Xiaocang Cao

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Topics

Transcription Factor

Gas Chromatography Mass Spectrometry

Top Venues

Nature communications

Microbiology spectrum

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

This page only lists publications with an associated author ORCID identifier.

Publications

Enze Fu, Meng Qian, Ningning He, Yilun Yin, Yue Liu, Zhibo Han, ZhongChao Han, Qiang Zhao, Xiaocang Cao, Zongjin Li
Biomimetic Supramolecular Assembly with IGF-1C Delivery Ameliorates Inflammatory Bowel Disease (IBD) by Restoring Intestinal Barrier Integrity. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2024)
Jiahao Wu, He Huang, Lina Wang, Mengxue Gao, Shuxian Meng, Shaolan Zou, Yuanhang Feng, Zeling Feng, Zhixin Zhu, Xiaocang Cao, Bingzhi Li, Guangbo Kang
A tailored series of engineered yeasts for the cell-dependent treatment of inflammatory bowel disease by rational butyrate supplementation. Gut microbes 16 (1) (2024)
Jiahao Wu, He Huang, Lina Wang, Mengxue Gao, Shuxian Meng, Shaolan Zou, Yuanhang Feng, Zeling Feng, Zhixin Zhu, Xiaocang Cao, Bingzhi Li, Guangbo Kang
A tailored series of engineered yeasts for the cell-dependent treatment of inflammatory bowel disease by rational butyrate supplementation. Gut microbes 16 (1) (2024)
Jiahao Wu, He Huang, Lina Wang, Mengxue Gao, Shuxian Meng, Shaolan Zou, Yuanhang Feng, Zeling Feng, Zhixin Zhu, Xiaocang Cao, Bingzhi Li, Guangbo Kang
A tailored series of engineered yeasts for the cell-dependent treatment of inflammatory bowel disease by rational butyrate supplementation. Gut microbes 16 (1) (2024)
Ying Wang, Jing Han, Guang Yang, Shuhui Zheng, Gaoshi Zhou, Xinjuan Liu, Xiaocang Cao, Guang Li, Bowen Zhang, Zhuo Xie, Li Li, Mudan Zhang, Xiaoling Li, Minhu Chen, Shenghong Zhang
Therapeutic potential of the secreted Kazal-type serine protease inhibitor SPINK4 in colitis. Nature communications 15 (1) (2024)
Ying Wang, Jing Han, Guang Yang, Shuhui Zheng, Gaoshi Zhou, Xinjuan Liu, Xiaocang Cao, Guang Li, Bowen Zhang, Zhuo Xie, Li Li, Mudan Zhang, Xiaoling Li, Minhu Chen, Shenghong Zhang
Therapeutic potential of the secreted Kazal-type serine protease inhibitor SPINK4 in colitis. Nature communications 15 (1) (2024)
Jiahao Wu, He Huang, Lina Wang, Mengxue Gao, Shuxian Meng, Shaolan Zou, Yuanhang Feng, Zeling Feng, Zhixin Zhu, Xiaocang Cao, Bingzhi Li, Guangbo Kang
A tailored series of engineered yeasts for the cell-dependent treatment of inflammatory bowel disease by rational butyrate supplementation. Gut microbes 16 (1) (2024)
Ying Wang, Jing Han, Guang Yang, Shuhui Zheng, Gaoshi Zhou, Xinjuan Liu, Xiaocang Cao, Guang Li, Bowen Zhang, Zhuo Xie, Li Li, Mudan Zhang, Xiaoling Li, Minhu Chen, Shenghong Zhang
Therapeutic potential of the secreted Kazal-type serine protease inhibitor SPINK4 in colitis. Nature communications 15 (1) (2024)
Mengfan Zhang, Yang Jing, Wenze Xu, Xiaojing Shi, Wenguang Zhang, Pengfei Chen, Xiaocang Cao, Xin-Wei Han, Xuhua Duan, Jian Zhuang Ren
The C-type lectin COLEC10 is predominantly produced by hepatic stellate cells and involved in the pathogenesis of liver fibrosis. Cell death & disease 14 (11) (2023)
Juan Du, Junlei Zhang, Lin Wang, Xun Wang, Yaxing Zhao, Jiaoying Lu, Tingmin Fan, Meng Niu, Jie Zhang, Fei Cheng, Jun Li, Qi Zhu, Daoqiang Zhang, Hao Pei, Guang Li, Xingguang Liang, He Huang, Xiaocang Cao, Xinjuan Liu, Wei Shao, Jianpeng Sheng
Selective oxidative protection leads to tissue topological changes orchestrated by macrophage during ulcerative colitis. Nature communications 14 (1) (2023)
Lina Wang, Xiaoming Cheng, Liang Bai, Mengxue Gao, Guangbo Kang, Xiaocang Cao, He Huang
Positive Interventional Effect of Engineered Butyrate-Producing Bacteria on Metabolic Disorders and Intestinal Flora Disruption in Obese Mice. Microbiology spectrum 10 (2) (2022)
Xiaocang Cao, Haibin Yuan, Jie Liang, He Huang
Elective Switching on Biosimilars: Far More Than Nonmedical Switching. Inflammatory bowel diseases 28 (7) (2022)